基础疾病负担对药物性肝损伤严重程度及预后的影响

肝脏 ›› 2022, Vol. 27 ›› Issue (1): 23-27.

基础疾病负担对药物性肝损伤严重程度及预后的影响

武亭, 王艳, 刘立伟, 李柯鑫, 王昱, 欧晓娟, 贾继东, 赵新颜, 马红

100050 首都医科大学附属北京友谊医院肝病中心,国家消化系统疾病临床医学研究中心

收稿日期:2021-05-28 出版日期:2022-01-31 发布日期:2022-02-11
通讯作者: 马红,Email:mahongmd@aliyun.com;赵新颜,Email:zhao_xinyan@ccmu.edu.cn
基金资助:
国家科技重大专项项目资助(2017ZX09304-016)

Influence of comorbidity on severity and prognosis of patients with DILI

WU Ting, WANG Yan, LIU Li-wei, LI Ke-xin, WANG Yu, OU Xiao-juan, JIA Ji-dong, ZHAO Xin-yan, MA Hong

Liver Research Center, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases,Beijing 100050,China

Received:2021-05-28 Online:2022-01-31 Published:2022-02-11
Contact: MA Hong, Email: mahongmd@aliyun.com;ZHAO Xin-yan, Email: zhao_xinyan@ccmu.edu.cn

摘要/Abstract

摘要： 目的探讨基础疾病对药物性肝损伤(drug-induced liver injury, DILI)患者严重程度及预后的影响。方法纳入北京友谊医院肝病中心2016年1月至2019年12月符合入排标准的DILI患者,依据查尔森合并症指数(Charlson Comorbidity Index, CCI)分为显著基础疾病负担组(CCI＞2分)和无或轻度基础疾病负担组(CCI≤2分),通过卡方检验及非参数检验分析两组患者临床特征、损伤程度及预后。结果 313例DILI患者年龄为(54±14)岁,女性227例(72.5%),其中无或轻度基础疾病负担的患者272例(86.9%),显著基础疾病负担的患者41例(13.1%)。与无或轻度基础疾病负担组相比,显著基础疾病负担组年龄更大[(63±8)岁比(52±14)岁]、体质指数[(24.2±5.2)比(23.1±3.6)kg/m²]及谷氨酰转肽酶[初始值 283.0(159.0,404.0)U/L比189.0(100.0,325.0)U/L;峰值 335.0(239.0,582.0)U/L比219.0(131.0,360.0)U/L]更高,差异均有统计学意义(均P＜0.01);严重程度及临床分型两组相比差异无统计学意义(P＞0.05)。在本队列中,250例(79.9%)DILI患者恢复正常,41例(13.1%)发展为慢性DILI,22例(7.0%)需要肝移植或者死亡,显著基础疾病负担组全因病死率及非肝脏相关的病死率均显著高于无或轻度基础病负担组患者(19.5%比3.7%; 12.2%比0.7%,均P＜0.01)。结论基础疾病负担重的患者预后差,以非肝脏相关死亡为主。

关键词: 药物性肝损伤, 合并症指数, 严重程度, 预后

Abstract: Objective To investigate the influence of comorbidity on severity and prognosis of patients with drug-induced liver injury (DILI).Methods DILI patients admitted to our hospital from January 2016 to December 2019 who met the inclusion criteria were enrolled. According to Charlson Comorbidity Index (CCI), they were divided into significant comorbidity group (CCI≤2) and none or mild comorbidity group (CCI > 2). The clinical characteristics, severity and prognosis between the 2 groups were analyzed by chi-square or non-parametric test.Results A total of 313 DILI patients were included, with an average age of 54±14 years, 227 of them were females (72.5%). There were 272 patients with mild or without comorbidity (86.9%) and 41 patients with significant comorbidity (13.1%). Compared with patients with mild or without comorbidity, patients with significant comorbidity were significantly older (63±8 vs 52±14), and had higher body mass index (24.2±5.2 vs 23.1±3.6) , higher gamma-glutamyl transferase (GGT) level [initial value: 283.0 (159.0-404.0) vs 189.0 (100.0-325.0), higher peak value [335.0 (239.0-582.0) vs 219.0 (131.0-360.0) ] (all P<0.05. There was no significant difference in severity and clinical classification between 2 groups. In this cohort, 250 (79.9%) patients were fully recovered, whereas 41 (13.1%) patients developed to chronic DILI and 22 (7.0%) patients underwent liver transplantation or death. Compared to none or mild comorbidity group, the all-cause mortality and non-liver related mortality were significant higher in significant comorbidity group (19.5% vs 3.7%; 12.2% vs 0.7% all P<0.01).Conclusion Patients with significant comorbidity had poor prognosis, the leading cause of death is non-liver related.

Key words: Drug-induced liver injury, Charlson Comorbidity Index, Severity, Prognosis

武亭, 王艳, 刘立伟, 李柯鑫, 王昱, 欧晓娟, 贾继东, 赵新颜, 马红. 基础疾病负担对药物性肝损伤严重程度及预后的影响[J]. 肝脏, 2022, 27(1): 23-27.

WU Ting, WANG Yan, LIU Li-wei, LI Ke-xin, WANG Yu, OU Xiao-juan, JIA Ji-dong, ZHAO Xin-yan, MA Hong. Influence of comorbidity on severity and prognosis of patients with DILI[J]. Chinese Hepatolgy, 2022, 27(1): 23-27.

参考文献

[1] EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol, 2019, 70: 1222-1261.
[2] Shen T, Liu Y, Shang J, et al. Incidence and etiology of drug-induced liver injury in Mainland China. Gastroenterology, 2019, 156: 2230-2241.
[3] Ghabril M, Gu J, Yoder L, et al. Development and validation of a model consisting of comorbidity burden to calculate risk of death within 6 months for patients with suspected drug-induced liver injury. Gastroenterology, 2019, 157: 1245-1252.
[4] Chalasani N, Bonkovsky H, Fontana R, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology, 2015, 148: 1340-1352.
[5] Charlson M, Pompei P, Ales K, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis, 1987, 40: 373-83.
[6] 于乐成, 茅益民, 陈成伟. 药物性肝损伤诊治指南. 实用肝脏病杂志, 2017, 20: 257-274.
[7] Aithal G, Watkins P, Andrade R, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther, 2011, 89: 806-15.
[8] Formiga F, Moreno-Gonzalez R, Chivite D, et al. High comorbidity, measured by the Charlson Comorbidity Index, associates with higher 1-year mortality risks in elderly patients experiencing a first acute heart failure hospitalization. Aging Clin Exp Res, 2018, 30: 927-933.
[9] Chalasani N, Hayashi P, Bonkovsky H, et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol, 2014, 109: 950-966.
[10] European Association for the Study of the Liver. Electronic Address E E E. EASL Clinical Practice Guidelines: vascular diseases of the liver. J Hepatol, 2016, 64: 179-202.
[11] Mclean A, Le Couteur D. Aging biology and geriatric clinical pharmacology. Pharmacol Rev, 2004, 56: 163-184.
[12] Mitchell S, Hilmer S. Drug-induced liver injury in older adults. Ther Adv Drug Saf, 2010, 1: 65-77.
[13] Weersink R, Alvarez-Alvarez I, Medina-Cáliz I, et al. Clinical characteristics and outcome of drug-induced liver injury in the older patients: from the young-old to the oldest-old. Clin Pharmacol Ther, 2021, 109: 1147-1158.
[14] 杨焕芝, 徐艳琼, 陈学平, et al. 药物性肝损伤住院患者预后影响因素的研究. 中国药物评价, 2020, 37: 222-227.
[15] Chalasani N, Fontana R, Bonkovsky H, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology, 2008, 135: 1924-1934.
[16] Li X, Xu H, Gao P. Increased red cell distribution width predicts severity of drug-induced liver injury: a retrospective study. Sci Rep, 2021, 11: 773.